ICO KYC Report
2 members invited
About FarmaTrust
Cross Platform
FarmaTrust works with any system, and is compatible with any platform. It is safe, secure, encrypted, and immutable.
Artificial Intelligence
FarmaTrust utilises AI technology to analyze data to create efficiency and interact with users.
Big Data
FarmaTrust system provides the most comprehensive data about the pharmaceutical industry in real time and globally.
Global
FarmaTrust system works internationally, with differing serial numbers, different regulations and different countries.
Whitepaper
Missing whitepaper? Let us know.
Ratings
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Igor Karavaev
Blockchain Enthusiast
Rated on Jan 4, 2018
Rated on Jan 4, 2018
5
5
4
5%
This rating's weight is reduced by 50% as there is no review added.
Vladimir Nikitin
Rated on Apr 24, 2018
Rated on Apr 24, 2018
5
5
4
5%
This rating's weight is reduced by 50% as there is no review added.
Luca Cotta
Icodriver...expert launching ICOs, ICO Influencer, IT expert.
Rated on Dec 31, 2017
Rated on Dec 31, 2017
4
4
4
10%
Nathan Christian
Blockchain Technology Consultant | DeFi | NFT | ICO - IDO - IEO
Rated on Dec 23, 2017
Rated on Dec 23, 2017
5
5
5
5%
This rating's weight is reduced by 50% as there is no review added.
Mofassair Hossain
CEO and Founder Perhalic, ICO and IEO Advisor, Investor, PR and Marketing Expert
Rated on Dec 24, 2017
Rated on Dec 24, 2017
5
4
4
5%
This rating's weight is reduced by 50% as there is no review added.
Ian Scarffe
Investor | Consultant | Blockchain Advisor | NFT Advisor | DeFi | Initial Dex Offering (IDO) | European Commission Expert
Rated on May 24, 2018
Rated on May 24, 2018
5
4
5
8%
Good use of the technology in a vital area. I like the look of the team and the vision is strong as well. Keep up the good work, guys, and I look forward to seeing the development!
+23Agree
+22
-1Disagree
Report
David Drake
Managing Partner
Rated on Apr 5, 2018
Rated on Apr 5, 2018
4
5
4
4%
This rating's weight is reduced by 50% as there is no review added.
Conston Taylor
ICO Advisor | ICO Analyst | Blockchain Researcher
Rated on Feb 7, 2018
Rated on Feb 7, 2018
5
5
5
8%
Strong Management Team, great concept and vision of eliminating counterfeit drugs. I would like to see a more detailed breakdown of the milestones, however this looks like a first rate project.
+1Agree
0
-1Disagree
Report
Purushotham Maralappa
Consulting Manager at Emurgo, Blockchain and Tokenization advisor
Rated on Feb 21, 2018
Rated on Feb 21, 2018
5
5
4
4%
This rating's weight is reduced by 50% as there is no review added.
Vlad Skakun
Co-Founder and CFO at CryptoDiffer | Investor| Marketing Specialist| Senior Analyst at Venture Fund
Rated on Mar 29, 2018
Rated on Mar 29, 2018
5
4
4
3%
This rating's weight is reduced by 50% as there is no review added.
Simon Choi
Fintech & ICO Lawyer
Rated on Dec 25, 2017
Rated on Dec 25, 2017
4
4
4
3%
This rating's weight is reduced by 50% as there is no review added.
Richard Kastelein
Publisher of Blockchain News (EST 2015), Director of Blockchain Partners, Director of Token.Agency
Rated on Feb 13, 2018
Rated on Feb 13, 2018
4
5
5
6%
I think the team is fairly strong and I like the vision. Supply chain in Health is critical. Medicine often needs to be kept at certain temperatures and security is an issue. Good idea, good team, well thought out, well done.
Agree
-2
-2Disagree
Report
P.B. Stanton Esq.
Securities and Banking law | Former US Marine JAG Officer | Complete legal advisory
Rated on Dec 25, 2017
Rated on Dec 25, 2017
5
4
4
3%
This rating's weight is reduced by 50% as there is no review added.
Marco Fike
director
Rated on Jan 5, 2018
Rated on Jan 5, 2018
5
4
4
2%
This rating's weight is reduced by 50% as there is no review added.
Tarek Roustom
M.D. and Venture capitalist
Rated on Jan 24, 2018
Rated on Jan 24, 2018
4
5
3
2%
This rating's weight is reduced by 50% as there is no review added.
Massimiliano Vurro
Rated on Mar 12, 2018
Rated on Mar 12, 2018
4
4
4
2%
This rating's weight is reduced by 50% as there is no review added.
Sebastian Spiteri
Rated on Dec 29, 2017
Rated on Dec 29, 2017
4
4
5
1%
This rating's weight is reduced by 50% as there is no review added.
Abhijith Naraparaju
Rated on Jan 25, 2018
Rated on Jan 25, 2018
5
4
4
1%
This rating's weight is reduced by 50% as there is no review added.
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
Press Releases
Blog
Financial
Token info
Token
FTT
Platform
Ethereum
Type
ERC20
PreICO price
1 FTT = 0.04 USD
Price in ICO
0.0500 USD
Average price
2.02 USD
Bonus
| Private Sale | 200m tokens | 40% |
| Institutional Sale | 150m tokens | 30% |
| Pre-Sale | 100m tokens | 20% |
| Public Sale | 100m tokens | |
| Bounty & Referral | 50m tokens |
Tokens for sale
600,000,000
Investment info
Min. investment
100 USD
Accepting
ETH, BTC, LTC, BCH, DASH, XRP, XMR, ZEC, Fiat
Distributed in ICO
60%
Soft cap
7,000,000 USD
Hard cap
20,250,000 USD
Milestones
1
Q1 2016
Identified the counterfeit drug problem
Researched the pharmaceutical market
Deep research into the problem
2
Q2 2016
Research into blockchain
How does it work
Discover available platforms
Identify the best platforms
3
Q3 2016
Search for blockchain engineers
Project details
Research code
4
Q4 2016
Developed first version
Full stack developers onboarded
Establish architecture and design
5
Q1 2017
Working prototype available
Provide demonstration of prototype
Inclusion of AI and machine learning
6
Q2 2017
Extend FarmaTrust management team
Explore financing options
Team structure changed
New IT members recruited
7
Q3 2017
Advisers sought and appointed
First drafts of whitepaper
Expansion of the product definiton
Demonstrate MVP to interested parties
8
Q4 2017
Private pre-sale
9
Q1 2018
Complete Dashboard MVP
Start Agile Smart Contract Design & Development
10
Q2 2018
Launch Extension of MVP
Complete platform product design
Complete Zoi framework
Complete UX Design
Continue App Design & Development
Finalise Technology Stack
Start Design and Development of AI Services & Data Analytics
Ready QA Infastructure
Token Distribution Event
11
Q3 2018
Release critical featuresets of Dashboard
Finalize Platform Scalability Design
POC Platform Scalability, Performance & Security
Continue API Design & Development
Continue APP Design & Development
Stress, Performance Test of API Ecosystem
Stress, Performance Test of Interoperability Interfaces
Start Exchange Design
Test Production Infrastructure Readiness
Complete Global Data Centre Design
Continue extension of Dashboard design, development & testing
Launch Pilot Client Implementations
Pre-TDE Completed
12
Q4 2018
Launch and Publish Apps to App Store and Play Store
Complete API development
Complete Exchange Design & Development
Continue Design of AI Services
13
Q1 2019
Launch API Gateway
Stress, Performance Test of Zoi Platform
Zoi Production Release
Zoi Exchange Release
Develop AI Services
Develop Data Analytics
14
Q2 2019
Global rollout of Data Centre
Zoi Platform Extension
Zoi Exchange Extension
Create Blockchain adaptor
End-to-End Testing of Zoi Platform extension
End-to-End Testing of Zoi Exchange extension